Friday, May 17, 2013

• EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDAMarketwired( (Fri, May 17)

Wednesday, May 1, 2013

• EnteroMedics Reports First Quarter 2013 Financial ResultsMarketwired( (Wed, May 1)

Monday, April 22, 2013

• EnteroMedics to Host First Quarter 2013 Financial Results Conference Call and Provide Business UpdateMarketwired( (Mon, Apr 22)

Tuesday, March 12, 2013

• EnteroMedics to Present at 25th Annual Roth Capital Partners ConferenceMarketwired( (Tue, Mar 12)

Wednesday, March 6, 2013

• EnteroMedics and Orexigen Therapeutics Look to Benefit as Medical Costs Associated With Obesity Surpasses SmokingMarketwired( (Wed, Mar 6)

Wednesday, February 27, 2013

• EnteroMedics Announces Closing of $13 Million Public Offering of Common Stock and WarrantsMarketwired( (Wed, Feb 27)

Tuesday, February 26, 2013

• EnteroMedics to Present at Cowen and Company 33rd Annual HealthCare ConferenceMarketwired( (Tue, Feb 26)

Friday, February 22, 2013

• EnteroMedics Announces Pricing of $13 Million Public Offering of Common Stock and WarrantsMarketwired( (Fri, Feb 22)

Thursday, February 21, 2013

• EnteroMedics Announces Proposed Public Offering of Common Stock and WarrantsMarketwired( (Thu, Feb 21)

Wednesday, February 20, 2013

• EnteroMedics Names Greg S. Lea Chief Operating OfficerMarketwired( (Wed, Feb 20)

Wednesday, February 13, 2013

• EnteroMedics Reports Fourth Quarter 2012 Financial ResultsMarketwired( (Wed, Feb 13)

Thursday, February 7, 2013

• EnteroMedics' ReCharge Trial Demonstrates Statistically Significant Weight Loss in Obesity But Does Not Meet Predefined Efficacy EndpointsMarketwired( (Thu, Feb 7)

Monday, November 19, 2012

• EnteroMedics to Present at Canaccord Genuity 2012 Medical Technology and Diagnostic ForumMarketwired( (Mon, Nov 19)